Skip to main content
Top

29-08-2014 | Pediatric leukemia | Article

Metabolic syndrome in childhood leukemia survivors: a meta-analysis

Journal: Endocrine

Authors: Maria Felicia Faienza, Maurizio Delvecchio, Paola Giordano, Luciano Cavallo, Maria Grano, Giacomina Brunetti, Annamaria Ventura

Publisher: Springer US

Abstract

A significant number of long-term complications have been described in childhood leukemia survivors. In particular, these patients may present features of metabolic syndrome (MetS), and therefore increased risk for cardiovascular diseases. The aim of this meta-analysis is to evaluate the prevalence and the risk of MetS in survivors of childhood leukemia. Two authors independently performed a systematic literature search in PubMed and EMBASE to March 2014, reviewed and selected articles, based on pre-determined selection criteria. Twelve articles, comprising 2,337 participants (1,462 cases and 875 controls), were included in the meta-analysis. Only three of them were case–control studies eligible for the meta-analysis. The childhood leukemia survivors showed an increased risk of MetS as compared to healthy controls (OR = 4.36; 95 % CI 1.19–16.22). The risk was significantly increased only in patients treated with chemotherapy and radiotherapy (OR = 7.79; 95 % CI 1.27–47.77), and not in patients treated with only chemotherapy (OR = 2.35; 95 % CI 0.40–13.78). Childhood leukemia survivors, in particular if treated also with radiotherapy, are prone to develop MetS more than healthy controls. Monitoring of MetS components in these patients is necessary to avoid cardiovascular consequences later in life.
Literature
1.
C.H. Pui, L.L. Robison, A.T. Look, Acute lymphoblastic leukemia. Lancet 371, 1030–1043 (2008)CrossRefPubMed
2.
A. Jemal, R. Siegel, J. Xu, E. Ward, Cancer statistics, 2010. CA Cancer J. Clin. 60, 277–300 (2010)CrossRefPubMed
3.
Scottish Intercollegiate Guidelines Network (SIGN), Long term follow up of survivors of childhood cancer (SIGN, Edinburgh, 2013). SIGN publication no. 132
4.
L.L. Robison, S. Bhatia, Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence. Br. J. Haematol. 122, 345–359 (2003)CrossRefPubMed
5.
K.C. Oeffinger, A.C. Mertens, C.A. Sklar, T. Kawashima, M.M. Hudson, A.T. Meadows, D.L. Friedman, N. Marina, W. Hobbie, N.S. Kadan-Lottick, C.L. Schwartz, W. Leisenring, L.L. Robison, Childhood Cancer Survivor Study: chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 355, 1572–1582 (2006)CrossRefPubMed
6.
R. Mody, S. Li, D.C. Dover, S. Sallan, W. Leisenring, K.C. Oeffinger, Y. Yasui, L.L. Robison, J.P. Neglia, Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 111, 5515–5523 (2008)CrossRefPubMedCentralPubMed
7.
M.J. Harila, S. Winqvist, M. Lanning, R. Bloigu, A.H. Harila-Saari, Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer 53, 156–161 (2009)CrossRefPubMed
8.
K.H. Darzy, S.M. Shalet, Hypopituitarism following radiotherapy revisited. Endocr Dev. 15, 1–24 (2009)PubMed
9.
L. Iughetti, P. Bruzzi, B. Predieri, P. Paolucci, Obesity in patients with acute lymphoblastic leukemia in childhood. Ital J Pediatr. 38, 4 (2012). doi:10.​1186/​1824-7288-38-4 CrossRefPubMedCentralPubMed
10.
N.J. van Casteren, G.H. van der Linden, F.G. Hakvoort-Cammel, K. Hählen, G.R. Dohle, M.M. van den Heuvel-Eibrink, Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr. Blood Cancer 52, 108–112 (2009)CrossRefPubMed
11.
C. Eiser, Beyond survival: quality of life and follow-up after childhood cancer. J. Pediatr. Psychol. 32, 1140–1150 (2007)CrossRefPubMed
12.
M. Delvecchio, V. Cecinati, L.P. Brescia, M.F. Faienza, D. De Mattia, L. Cavallo, N. Santoro, Thyroid function and thyroid autoimmunity in childhood acute lymphoblastic leukemia off-therapy patients treated only with chemotherapy. J. Endocrinol. Invest. 33, 135–139 (2010)CrossRefPubMed
13.
K.C. Oeffinger, G.R. Buchanan, D.A. Eshelman, M.A. Denke, T.C. Andrews, J.A. Germak, G.E. Tomlinson, L.E. Snell, B.M. Foster, Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematolol Oncol. 23, 424–430 (2001)CrossRef
14.
K. Link, C. Moëll, S. Garwicz, E. Cavallin-Ståhl, J. Björk, U. Thilén, B. Ahrén, E.M. Erfurth, Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J. Clin. Endocrinol. Metab. 89, 5003–5012 (2004)CrossRefPubMed
15.
J.G. Gurney, K.K. Ness, S.D. Sibley, M. O’Leary, D.R. Dengel, J.M. Lee, N.M. Youngren, S.P. Glasser, K.S. Baker, Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107, 1303–1312 (2006)CrossRefPubMed
16.
P.M. Janiszewski, K.C. Oeffinger, T.S. Church, A.L. Dunn, D.A. Eshelman, R.G. Victor, S. Brooks, A.J. Turoff, E. Sinclair, J.C. Murray, L. Bashore, R. Ross, Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J. Clin. Endocrinol. Metab. 92, 3816–3821 (2007)CrossRefPubMed
17.
B.I. Razzouk, S.R. Rose, S. Hongeng, D. Wallace, M.P. Smeltzer, M. Zacher, C.H. Pui, M.M. Hudson, Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J. Clin. Oncol. 25, 1183–1189 (2007)CrossRefPubMed
18.
G. Trimis, M. Moschovi, I. Papassotiriou, G. Chrousos, F. Tzortzatou-Stathopoulou, Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J. Pediatr. Hematol. Oncol. 29, 309–314 (2007)CrossRefPubMed
19.
M. Jarfelt, B. Lannering, I. Bosaeus, G. Johannsson, R. Bjarnason, Body composition in young adult survivors of childhood acute lymphoblastic leukemia. Eur. J. Endocrinol. 153, 81–89 (2005)CrossRefPubMed
20.
M. Kourti, A. Tragiannidis, A. Makedou, T. Papageorgiou, I. Rousso, F. Athanassiadou, Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J. Pediatr. Hematol. Oncol. 27, 499–501 (2005)CrossRefPubMed
21.
N. Reisi, A. Azhir, M. Hashemipour, P. Raeissi, A. Amini, A. Moafi, The metabolic syndrome in survivors of childhood acute lymphoblastic leukemia in Isfahan. Iran. J Res Med Sci. 14, 111–116 (2009)
22.
C. Follin, U. Thilén, B. Ahrén, E.M. Erfurth, Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J. Clin. Endocrinol. Metab. 91, 1872–1875 (2006)CrossRefPubMed
23.
E.J. Chow, J.H. Simmons, C.L. Roth, K.S. Baker, P.A. Hoffmeister, J.E. Sanders, D.L. Friedman, Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant. 16, 1674–1681 (2010)CrossRefPubMedCentralPubMed
24.
C. Oudin, M.C. Simeoni, N. Sirvent, A. Contet, Begu-Le Coroller, A., Bordigoni, P., Curtillet, C., Poirée, M., Thuret, I., Play, B., Massot, M.C., Chastagner, P., Chambost, H., Auquier, P., Michel, G.: prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 117, 4442–4448 (2011)CrossRefPubMed
25.
H. Karakurt, N. Sarper, S.Ç. Kılıç, S.A. Gelen, E. Zengin, Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance. Pediatr. Hematol. Oncol. 29, 551–561 (2012)CrossRefPubMed
26.
F. Aldhafiri, A. Al-Nasser, A. Al-Sugair, H. Al-Mutairi, D. Young, J.J. Reilly, Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia. Pediatr. Blood Cancer 59, 133–137 (2012)CrossRefPubMed
27.
K. Blijdorp, M. van Waas, A.J. van der Lely, R. Pieters, M. van den Heuvel-Eibrink, S. Neggers, Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia. Leuk. Res. 37, 367–371 (2013)CrossRefPubMed
28.
K.K. Ness, W. Leisenring, P. Goodman, T. Kawashima, A.C. Mertens, K.C. Oeffinger, G.T. Armstrong, L.L. Robison, Assessment of selection bias in clinic-based populations of childhood cancer survivors: a report from the childhood cancer survivor study. Pediatr. Blood Cancer 52, 379–386 (2009)CrossRefPubMedCentralPubMed
29.
K.A. Nottage, K.K. Ness, C. Li, D. Srivastava, L.L. Robison, M.M. Hudson, Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukemia - From the St. Jude Lifetime Cohort. Br J Haematol. 165, 364–374 (2014)CrossRef
30.
L. Ramphal, J. Zhang, S. Suzuki, Ethnic disparities in the prevalence of the metabolic syndrome in American adults: data from the Examination of National Health and Nutrition Examination Survey 1999-2010. Proc (Bayl Univ Med Cent). 27, 92–95 (2014)PubMedCentralPubMed
31.
J.P. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002)CrossRefPubMed
32.
K.C. Oeffinger, A.C. Mertens, C.A. Sklar, Y. Yasui, T. Fears, M. Stovall, T.A. Vik, P.D. Inskip, L.L. Robison, Childhood Cancer Survivor Study: obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 21, 1359–1365 (2003)CrossRefPubMed
33.
K.A. Neville, R.J. Cohn, K.S. Steinbeck, K. Johnston, J.L. Walker, Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J. Clin. Endocrinol. Metab. 91, 4401–4407 (2006)CrossRefPubMed
34.
M. Taskinen, U.M. Saarinen-Pihkala, L. Hovi, M. Lipsanen-Nyman, Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356, 993–997 (2000)CrossRefPubMed
35.
S. Pietilä, A. Mäkipernaa, H. Sievänen, A.M. Koivisto, T. Wigren, H.L. Lenko, Obesity and metabolic changes are common in young childhood brain tumor survivors. Pediatr. Blood Cancer 52, 853–859 (2009)CrossRefPubMed
36.
J.G. Gurney, K.K. Ness, M. Stovall, S. Wolden, J.A. Punyko, J.P. Neglia, A.C. Mertens, R.J. Packer, L.L. Robison, C.A. Sklar, Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J. Clin. Endocrinol. Metab. 88, 4731–4739 (2003)CrossRefPubMed
37.
E.I. Mayer, M. Reuter, R.E. Dopfer, M.B. Ranke, Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm. Res. 53, 193–199 (2000)CrossRefPubMed
38.
B.M. Brennan, A. Rahim, W.F. Blum, J.A. Adams, O.B. Eden, S.M. Shalet, Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol (Oxf). 50, 163–169 (1999)CrossRefPubMed
39.
K. He, K. Liu, M.L. Daviglus, S.J. Morris, C.M. Loria, L. Van Horn, D.R. Jacobs Jr, P.J. Savage, Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113, 1675–1682 (2006)CrossRefPubMed
40.
H. Lajer, H. Bundgaard, N.H. Secher, H.H. Hansen, K. Kjeldsen, G. Daugaard, Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin. Br. J. Cancer 89, 1633–1637 (2003)CrossRefPubMedCentralPubMed
41.
J. Nuver, A.J. Smit, J. van Der Meer, M.P. van Den Berg, W.T. van der Graaf, M.T. Meinardi, D.T. Sleijfer, H.J. Hoekstra, A.I. van Gessel, A.M. van Roon, J.A. Gietema, Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 23, 9130–9137 (2005)CrossRefPubMed
42.
J.A. Kim, M. Montagnani, K.K. Koh, M.J. Quon, Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888–1904 (2006)CrossRefPubMed
43.
K.K. Ness, M.M. Hudson, J.P. Ginsberg, R. Nagarajan, S.C. Kaste, N. Marina, J. Whitton, L.L. Robison, J.G. Gurney, Physical performance limitations in the Childhood Cancer Survivor Study cohort. J. Clin. Oncol. 27, 2382–2389 (2009)CrossRefPubMedCentralPubMed
44.
D.R. Herman, P.A. Ganz, L. Petersen, G.A. Greendale, Obesity and cardiovascular risk factors in younger breast cancer survivors: the cancer and menopause study (CAMS). Breast Cancer Res. Treat. 93, 13–23 (2005)CrossRefPubMed
45.
K.S. Baker, K.K. Ness, J. Steinberger, A. Carter, L. Francisco, L.J. Burns, C. Sklar, S. Forman, D. Weisdorf, J.G. Gurney, S. Bhatia, Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109, 1765–1772 (2007)CrossRefPubMed
46.
A. Tichelli, S. Bhatia, G. Socié, Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br. J. Haematol. 142, 11–26 (2008)CrossRefPubMed
47.
L.R. Meacham, E.J. Chow, K.K. Ness, K.Y. Kamdar, Y. Chen, Y. Yasui, K.C. Oeffinger, C.A. Sklar, L.L. Robison, A.C. Mertens, Cardiovascular risk factors in adult survivors of pediatric cancer–a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 19, 170–181 (2010)CrossRefPubMedCentralPubMed
48.
M. Steffens, V. Beauloye, B. Brichard, A. Robert, O. Alexopoulou, Ch. Vermylen, D. Maiter, Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol (Oxf). 69, 819–827 (2008)CrossRefPubMed
49.
M. van Waas, S.J. Neggers, A.J. van der Lelij, R. Pieters, M.M. van den Heuvel-Eibrink, The metabolic syndrome in adult survivors of childhood cancer, a review. J. Pediatr. Hematol. Oncol. 32, 171–179 (2010)CrossRefPubMed
50.
C.M. Brownstein, A.C. Mertens, P.A. Mitby, M. Stovall, J. Qin, G. Heller, L.L. Robison, C.A. Sklar, Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 89, 4422–4427 (2004)CrossRefPubMed